| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |